Novavax Inc said on Wednesday it would acquire a manufacturing plant in the Czech Republic for $167 million as the drug developer aims to enhance capacity to produce its COVID-19 vaccine prospect. Novavax, among the handful of companies aiming to develop a vaccine for COVID-19, said on Monday that it enrolled its very first participant in an early stag